SONORIPPLE
LIVE

Serial Number

99348365

Owner

SonoThera, Inc.

Attorney

Dustin Luettgen

Filing Date

Aug 20, 2025

Add to watchlist:

No watchlists yet
View on USPTO

SONORIPPLE Trademark

Serial Number: 99348365

SONORIPPLE is a trademark filed by SonoThera, Inc. on August 20, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

SonoThera, Inc. (7 trademarks)

201 Haskins Way
South San Francisco, CA 94080

Entity Type: 03

Trademark Details

Filing Date

August 20, 2025

Registration Date

Not Registered

Goods & Services

Software as a service (SAAS) services featuring software for operating ultrasound systems and ultrasound probes that administer pharmaceutical agents being biological preparations and gene therapy preparations for the treatment of human diseases and disorders.

Gene therapy preparations, namely, biological preparations for the treatment of human diseases and disorders being diseases of genetic and genetic predisposition etiology; kits comprised of gene therapies, namely, biological preparations and pharmaceutical preparations both for the treatment of human diseases and disorders being diseases of genetic and genetic predisposition etiology; gene delivery platform in the nature of biological delivery agents, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals for the treatment of human diseases and disorders being diseases of genetic and genetic predisposition etiology.

Downloadable computer operating software for operating ultrasound systems and ultrasound probes that are used for administering pharmaceutical agents being biological preparations and gene therapy preparations for the treatment of human diseases and disorders.

Ultrasound systems being medical ultrasound apparatus and ultrasound probes for medical use for administering pharmaceutical agents being biological preparations and gene therapy preparations for the treatment of human diseases and disorders.

Filing History

TEAS/EMAIL CORRESPONDENCE ENTERED
May 22, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 22, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 22, 2026 TROA
TEAS REQUEST TO DIVIDE RECEIVED
May 22, 2026 ERTD
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Apr 17, 2026 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Apr 17, 2026 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 20, 2026 GNRN
NON-FINAL ACTION E-MAILED
Jan 20, 2026 GNRT
NON-FINAL ACTION WRITTEN
Jan 20, 2026 CNRT
ASSIGNED TO EXAMINER
Jan 9, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 8, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Aug 20, 2025 MAFR
NEW APPLICATION ENTERED
Aug 20, 2025 NWAP